Novolizer Salbutamol (Salbutamol Sulfate)

Novolizer Salbutamol is a short‑acting β2‑agonist that acts on the bronchial smooth‑muscle pathway to relieve reversible airway obstruction.

• Asthma: rapid relief of acute bronchospasm and prevention of exercise‑induced symptoms.
• Chronic obstructive pulmonary disease (COPD): short‑term bronchodilation to improve airflow during exacerbations.
• Exercise‑induced bronchoconstriction: prophylactic bronchodilation when administered before physical activity.

• Salbutamol binds selectively to β2‑adrenergic receptors on bronchial smooth muscle, activating adenylate cyclase and increasing intracellular cyclic AMP. The rise in cAMP leads to relaxation of smooth muscle fibers, producing bronchodilation and improved airway patency. The effect is rapid, reversible, and primarily localized to the lungs when delivered by inhalation.

Adverse reactions to inhaled salbutamol are generally dose‑related and may vary between individuals.

Common Side Effects

• Tremor: mild shaking of the hands or limbs.
• Headache: transient headache episodes.
• Palpitations: sensation of rapid or irregular heartbeat.
• Throat irritation: mild discomfort or dryness in the throat.
• Cough: brief coughing after inhalation.
• Nausea: occasional feeling of queasiness.

Serious or Rare Side Effects

• Paradoxical bronchospasm: worsening airway narrowing after inhalation.
• Severe tachycardia: markedly increased heart rate requiring medical attention.
• Hypokalemia: low blood potassium levels detectable on laboratory testing.
• Angio‑edema: swelling of the face, lips or tongue.
• Anaphylactic reaction: rare systemic allergic response.
• Cardiac arrhythmia: abnormal heart rhythm potentially requiring intervention.

When using Novolizer Salbutamol, consider the following safety measures:

• Assess asthma control: ensure the patient’s baseline asthma is adequately managed before relying on rescue inhaler use.
• Monitor cardiovascular status: watch for rapid heart rate or palpitations, especially in patients with known heart disease.
• Avoid excessive use: limit rescue inhalations to the prescribed maximum to reduce risk of tolerance and side effects.
• Review concomitant medications: check for other β‑agonists or sympathomimetics that may amplify effects.
• Store at ambient temperature: keep below 25°C, retain in original packaging, and protect from moisture.

Salbutamol may interact with several drug classes, influencing its safety or efficacy.

Major Interactions (Avoid)

• Non‑selective β‑blockers: may diminish bronchodilator response and precipitate bronchospasm.
• Diuretics (especially loop diuretics): can exacerbate hypokalemia when combined with salbutamma.

Moderate Interactions (Monitor Closely)

• MAO‑inhibitors and tricyclic antidepressants: may increase the risk of cardiovascular side effects.
• Theophylline: additive bronchodilator effect may heighten tremor or tachycardia.
• High‑dose inhaled corticosteroids: may mask worsening asthma control, delaying needed adjustments.
• Beta‑agonist combination inhalers: concurrent use can increase systemic exposure.